Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 13/20 | 0.50 |
| ▸ | LIPG | Q9Y5X9 | 13/20 | 0.50 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 3/20 | 0.36 |
| ▸ | CA2 | P00918 | 3/20 | 0.36 |
| ▸ | CA9 | Q16790 | 3/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA3 | P07451 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
| ▸ | CA6 | P23280 | 1/20 | 0.36 |
| ▸ | CA5A | P35218 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.36 |
| ▸ | F11 | P03951 | 1/20 | 0.35 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22771042 | 0.88 | LPL (0.44) | LPLLIPGROCK1CA1CA2 | |
| SCHEMBL14956694 | 0.87 | LPL (0.43) | LPLLIPGROCK1CA1CA2 | |
| SCHEMBL12327213 | 0.87 | LPL (0.43) | LPLLIPGROCK1CA1CA2 | |
| SCHEMBL16655624 | 0.87 | LPL (0.43) | LPLLIPGROCK1CA1CA2 | |
| SCHEMBL26153570 | 0.85 | LPL (0.48) | LPLLIPGROCK1CA1CA2 | |
| SCHEMBL19804941 | 0.84 | LPL (0.41) | LPLLIPGROCK1CA1CA2 | |
| SCHEMBL14274294 | 0.84 | LPL (0.41) | LPLLIPGROCK1CA1CA2 | |
| SCHEMBL30129305 | 0.84 | LPL (0.41) | LPLLIPGROCK1CA1CA2 | |
| SCHEMBL16655990 | 0.84 | LPL (0.41) | LPLLIPGROCK1CA1CA2 | |
| SCHEMBL587558 | 0.83 | LPL (0.47) | LPLLIPGROCK1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12633548-B2 | Eliminating voltage delay and stabilizing impedance by electrolyte additives in alkali metal electrochemical cells | LITRONIK BATTERIETECHNOLOGIE GMBH (DE) | 2026-05-19 | — | — | US | claimed |
| CN-117486916-B | Synthesis method of 3,4, 5-trifluoro-phenylboronic acid | 山东国邦药业有限公司 | 2024-04-12 | — | — | CN | claimed |
| CN-117486916-A | Synthesis method of 3,4, 5-trifluoro-phenylboronic acid | 山东国邦药业有限公司 | 2024-02-02 | — | — | CN | claimed |
| US-20220263102-A1 | ELIMINATING VOLTAGE DELAY AND STABILIZING IMPEDANCE BY ELECTROLYTE ADDITIVES IN ALKALI METAL ELECTROCHEMICAL CELLS | LITRONIK BATTERIETECHNOLOGIE GMBH (DE) | 2022-08-18 | — | — | US | claimed |
| EP-3997748-A1 | ELIMINATION OF VOLTAGE DELAY AND STABILIZATION OF IMPEDANCE BY ELECTROLYTE ADDITIVES IN ALKALI METAL ELECTROCHEMICAL CELLS | LITRONIK Batterietechnologie GmbH (DE) | 2022-05-18 | — | — | EP | claimed |
| US-12633548-B2 | Eliminating voltage delay and stabilizing impedance by electrolyte additives in alkali metal electrochemical cells | LITRONIK BATTERIETECHNOLOGIE GMBH (DE) | 2026-05-19 | — | — | US | disclosed |
| WO-2025070482-A1 | COMPOUND, LIGHT-EMITTING MATERIAL, AND ORGANIC LIGHT-EMITTING ELEMENT | 株式会社Kyulux | 2025-04-03 | — | — | WO | disclosed |
| US-20250026778-A1 | GALACTOSIDE DERIVATIVE AS GALECTIN-3 INHIBITOR | TIUMBIO CO., LTD. (KR) | 2025-01-23 | — | — | US | disclosed |
| US-12178122-B2 | Compound, composition including the same, liquid composition, and organic electroluminescent device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2024-12-24 | — | — | US | disclosed |
| EP-4448102-A1 | NEW COMPOUND FOR THE TREATMENT AND PROPHYLAXIS OF INFECTIOUS DISEASES | Eberhard Karls Universität Tübingen, Medizinische Fakultät (DE) | 2024-10-23 | — | — | EP | disclosed |
| US-20240336573-A1 | COMPOUND FOR THE TREATMENT AND PROPHYLAXIS OF INFECTIOUS DISEASES | UNIVERSITEIT ANTWERPEN (BE) | 2024-10-10 | — | — | US | disclosed |
| CN-116444499-B | Phenylalanine derivative containing 4-quinazolinone and preparation method and application thereof | 山东大学 | 2024-09-06 | — | — | CN | disclosed |
| WO-2014209034-A1 | BIARYL DERIVATIVES AS GPR120 AGONISTS | LG LIFE SCIENCES LTD. (KR) | 2014-12-31 | — | — | WO | disclosed |
| US-8637710-B2 | Catalyst for cross-coupling reaction comprising unsubstituted or substituted bisphosphinobenzenes | KYOTO UNIVERSITY (JP) | 2014-01-28 | — | — | US | disclosed |
| US-8637710-B2 | Catalyst for cross-coupling reaction comprising unsubstituted or substituted bisphosphinobenzenes | KYOTO UNIVERSITY (JP) | 2014-01-28 | — | — | US | disclosed |
| US-20110152523-A1 | CATALYST FOR CROSS-COUPLING REACTION, AND PROCESS FOR PRODUCTION OF AROMATIC COMPOUND USING THE SAME | KYOTO UNIVERSITY (JP) | 2011-06-23 | — | — | US | disclosed |
| EP-1137641-B1 | PROCESS FOR PREPARING PYRIDAZIN-3-ON DERIVATIVES | SUMITOMO CHEMICAL CO (JP) | 2004-11-10 | — | — | EP | disclosed |
| US-6500951-B1 | RING CLOSING A CARBOXYLIC ACID DERIVATIVE IN PRESENCE OF A NITROGEN CONTAINING AROMATIC COMPOUND AND A BORON COMPOUND; HIGH YIELD AND PURITY | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-12-31 | — | — | US | disclosed |
| EP-1137641-A1 | PROCESS FOR PREPARING PYRIDAZIN-3-ON DERIVATIVES | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2001-10-04 | — | — | EP | disclosed |
| WO-2000034249-A1 | PROCESS FOR PREPARING PYRIDAZIN-3-ON DERIVATIVES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2000-06-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12178122-B2 | Compound, composition including the same, liquid composition, and organic electroluminescent device | TERT, TELO2, POT1 | LPL 1723/4885LIPG 2234/4885ROCK1 1743/4885 |
| US-20240336573-A1 | COMPOUND FOR THE TREATMENT AND PROPHYLAXIS OF INFECTIOUS DISEASES | TLR1, TLR5, TLR4 | LPL 803/4885LIPG 1286/4885ROCK1 3575/4885 |
| US-20110152523-A1 | CATALYST FOR CROSS-COUPLING REACTION, AND PROCESS FOR PRODUCTION OF AROMATIC COMPOUND USING THE SAME | AHR, AR, HRH2 | LPL 4860/4885LIPG 4876/4885ROCK1 2570/4885 |
| US-20250026778-A1 | GALACTOSIDE DERIVATIVE AS GALECTIN-3 INHIBITOR | LGALS3, LGALS1, LGALS3BP | LPL 1685/4885LIPG 1374/4885ROCK1 1037/4885 |
| US-12633548-B2 | Eliminating voltage delay and stabilizing impedance by electrolyte additives in alkali metal electrochemical cells | KCNN1, HCN4, KCNN2 | LPL 4624/4885LIPG 4122/4885ROCK1 3186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.